Cordant Inc’s Labcorp LH Stock Holding History

Cordant Inc’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-27	Closed	-$6K	–	719
2022 Q1	$6K	Buy	+27	New	+$6.35K	﹤0.01%	213

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cordant Inc's LH Position: Q2 2022 in Review

Cordant Inc sold out of Labcorp (LH) in Q2 2022, closing a stake of 27 shares — an estimated $6K sold.

Cordant Inc first reported a position in LH in Q1 2022 and held it in 1 quarter. The position peaked at $6K in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

Cordant Inc reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 27 Labcorp shares in Q2 2022, an estimated $6K.
Cordant Inc first reported a position in Labcorp in Q1 2022 and held it in 1 quarter.
Cordant Inc's Labcorp position peaked at $6K in Q1 2022.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.